This inventor holds 3 USPTO granted patents and 7 published patent applications and 7 EPO patents. Top assignee: Bayer Aktiengesellschaft. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Katrin Nowak-Reppel: Innovator in Pharmaceutical Research
Introduction
Katrin Nowak-Reppel is a notable inventor based in Berlin, Germany. She has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds for treating autoimmune diseases and hyperproliferative disorders. Although she currently holds no granted patents, her work is recognized for its potential impact on medical treatments.
Latest Patent Applications
Katrin's latest patent applications include:
1. **Furoindazole Derivatives as GPR84 Antagonists** - This invention covers furoindazole compounds that are designed to treat various autoimmune diseases such as multiple sclerosis, psoriasis, and rheumatoid arthritis, among others. The application details methods of preparing these compounds and their pharmaceutical compositions.
2. **Phosphorus Derivatives as Novel SOS1 Inhibitors** - This application focuses on phosphorus derivatives aimed at treating hyperproliferative disorders associated with SOS1. It includes methods for preparing these compounds and their use in pharmaceutical compositions.
Conclusion
Katrin Nowak-Reppel's innovative work in pharmaceutical research highlights her commitment to advancing medical science. Her latest patent applications reflect her dedication to developing effective treatments for complex diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile